Transepicardial With Transseptal Autologous CD 133+ Bone Marrow Cell Implantation in Patient Following CABG Surgery

NCT02870933 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease

Interventions

BIOLOGICAL: Transepicardial with Transseptal CD 133+ Implantation

Sponsor

National Cardiovascular Center Harapan Kita Hospital Indonesia